DiaMedica Therapeutics Inc. is a biopharmaceutical company focusing on the development and commercialization of novel treatments for neurological and kidney diseases. With a strong pipeline and a dedicated team, DiaMedica is poised to make a significant impact in improving patients’ lives.
